
Regulatory report: US state-by-state taxation of medical cannabis
8th March 2022 - Regulatory reports |
This report covers, state by state, the widely differing tax policies for medical cannabis in the US
This report covers, state by state, the widely differing tax policies for medical cannabis in the US
Costa Rican president Carlos Alvarado ratified a bill on 2nd March that legalises the sale and distribution of medicinal cannabis and allows for the commercial production of hemp in the Central American nation
Hemp companies are poised to benefit from a new law in New York put forward to help ease supply issues that often occur when a state opens up a legal recreational cannabis market
Covers: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama. Overall, the region is restrictive on hemp and cannabis, with exceptions being Belize, Costa Rica and Panama
CBD-Intel has compiled and classified regulatory data on medical and recreational cannabis in over 50 jurisdictions around the world. This report is accompanied by a detailed database outlining the regulatory situation in selected countries
A bill originally aimed at restricting the shapes that edible cannabis products may take has morphed into a potential significant threat to CBD products in Virginia
One of the most prestigious cannabis legalisation lobbying groups has come out with a disappointing – but not surprising – strong line against hemp-derived delta-8 THC products
An Italian referendum on the potential decriminalisation of cannabis for personal use has been rejected by the country’s Constitutional Court
Mississippi has finally signed a medical cannabis bill into law after a long and often arduous process.
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
Notifications